Sit Investment Associates’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-51,900
Closed -$2.39M 558
2018
Q2
$2.39M Sell
51,900
-16,900
-25% -$748K 0.06% 267
2018
Q1
$2.73M Sell
68,800
-2,400
-3% -$88.9K 0.07% 256
2017
Q4
$2.38M Sell
71,200
-7,000
-9% -$249K 0.06% 271
2017
Q3
$2.9M Buy
78,200
+6,325
+9% +$238K 0.07% 241
2017
Q2
$2.66M Sell
71,875
-625
-0.9% -$20.4K 0.07% 246
2017
Q1
$2.04M Buy
+72,500
New +$2.05M 0.05% 275

Other funds holding PAHC

Sit Investment Associates's PAHC Position: Q3 2018 in Review

Sit Investment Associates sold out of Phibro Animal Health (PAHC) in Q3 2018, closing a stake of 51,900 shares — an estimated $2.39M sold.

Sit Investment Associates first reported a position in PAHC in Q1 2017 and held it in 6 quarters. The position peaked at $2.9M in Q3 2017. 191 funds tracked by Wall St. Rank hold PAHC as of Q3 2018.

  • Sit Investment Associates reported no remaining Phibro Animal Health position as of Q3 2018 after selling out during the quarter.
  • Sit Investment Associates sold 51,900 Phibro Animal Health shares in Q3 2018, an estimated $2.39M.
  • Sit Investment Associates first reported a position in Phibro Animal Health in Q1 2017 and held it in 6 quarters.
  • Sit Investment Associates's Phibro Animal Health position peaked at $2.9M in Q3 2017.
  • 191 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2018.

Based on Sit Investment Associates's 13F filing for Q3 2018, filed 14 Nov 2018.